Literature DB >> 34244766

Essential oils for blood-brain barrier disruption: Preclinical studies of NEO100 in breast cancer brain metastases.

Rimas V Lukas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34244766      PMCID： PMC8485433          DOI： 10.1093/neuonc/noab167

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  8 in total

1.  Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.

Authors:  Janaína Fernandes; Clovis Orlando da Fonseca; Anselmo Teixeira; Cerli Rocha Gattass
Journal:  Oncol Rep       Date:  2005-05       Impact factor: 3.906

2.  Overcoming the Blood-Brain Barrier with an Implantable Ultrasound Device.

Authors:  Adam M Sonabend; Roger Stupp
Journal:  Clin Cancer Res       Date:  2019-05-10       Impact factor: 12.531

3.  NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics.

Authors:  Weijun Wang; Nagore I Marín-Ramos; Haiping He; Shan Zeng; Hee-Yeon Cho; Stephen D Swenson; Long Zheng; Alan L Epstein; Axel H Schönthal; Florence M Hofman; Ligang Chen; Thomas C Chen
Journal:  Neuro Oncol       Date:  2021-01-30       Impact factor: 12.300

4.  Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer.

Authors:  Weijun Wang; Haiping He; Nagore I Marín-Ramos; Shan Zeng; Steven D Swenson; Hee-Yeon Cho; Jie Fu; Paul M Beringer; Josh Neman; Ligang Chen; Axel H Schönthal; Thomas C Chen
Journal:  Neuro Oncol       Date:  2021-10-01       Impact factor: 12.300

5.  Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.

Authors:  Scott R Burks; Cymon N Kersch; Jaclyn A Witko; Michael A Pagel; Maggie Sundby; Leslie L Muldoon; Edward A Neuwelt; Joseph A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

6.  Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.

Authors:  Axel H Schönthal; David M Peereboom; Naveed Wagle; Rose Lai; Anna J Mathew; Kyle M Hurth; Vincent F Simmon; Steven P Howard; Lynne P Taylor; Frances Chow; Clovis O da Fonseca; Thomas C Chen
Journal:  Neurooncol Adv       Date:  2021-02-12

Review 7.  Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.

Authors:  Kevin Beccaria; Aria Sabbagh; John de Groot; Michael Canney; Alexandre Carpentier; Amy B Heimberger
Journal:  J Neurooncol       Date:  2020-02-28       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.